Kimia Farma continues to strengthen its commitment as a cornerstone of national health resilience by supporting the development of the regenerative medicine ecosystem in Indonesia through scientific education and collaboration with medical professionals.
This commitment is demonstrated through Kimia Farma’s participation in ARUNA 2026, an event bringing together dermatologists, aesthetic physicians, plastic surgeons, academics, and researchers, as well as stakeholders from the national and international healthcare industries.
As part of this event, Kimia Farma participated in a scientific symposium alongside Prof. Dr. dr. Lili Legiawati, Sp.D.V.E., Subsp.D.K.E., FINSDV, FAADV, aiming to foster an understanding of regenerative medicine that is evidence-based, safe, and responsible.
Through collaboration and continuous education, Kimia Farma is committed to driving advancements in healthcare services and the development of regenerative medicine in Indonesia.